Substituted dimeric compounds
US6310074A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | May 18, 2000 |
| Grant date | Oct 30, 2001 |
| Priority date | — |
| Expiry date | May 18, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compound of formula (I): EQU A--G.sub.1 --Cy--G.sub.2 --Cy'--G.sub.3 --B (I) wherein: PA1 A represents a grouping NR.sup.1 C(Q)R.sup.2, C(Q)NR.sup.2 R.sup.3 or NR.sup.1 C(Q)NR.sup.2 R.sup.3, PA1 B represents a grouping NR.sup.1 C(Q)R.sup.2, NR.sup.1 C(Q)NR.sup.2 R.sup.3, C(Q)NR.sup.2 R.sup.3, C(Q)OR.sup.1, NR.sup.1 C(Q)OR.sup.2 or NR.sup.2 R.sup.3, PA1 G.sub.1 and G.sub.3 represent an optionally substituted alkylene chain, PA1 Cy and Cy', which are different, represent a ring structure ##STR1## or ##STR2## PA1 G.sub.2 represents a chain ##STR3## and medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.